tirzepatide cease and desist letter A company called Nomida has received an FDA warning for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved Semaglutide "kits" The fun never ends. Let’s

For example, driving, flying, water sports, skiing, using complex or heavy machinery, or farm machinery

10.1055/s-0031-1298021 49 LiX.YangC.ShenH

A recently published ACC scientific statement highlighted major findings showing cardiovascular benefits from both semaglutide (GLP1 RA) and tirzepatide (GLP1/GIP RA)including improvements in cardiac structure and functiondemonstrating lower rates of heart failure and major cardiovascular events

The medication creates a window of opportunity

Both semaglutide and tirzepatide activate GLP-1 pathways and trigger similar metabolic changes, so cold sensitivity is common with both medications